News und Analysen
AEVIS VICTORIA SA – AEVS.SW – Visana enters into the share capital of Hôpital du Jura Bernois, a subsidiary of Swiss Medical Network
EQS-News: Evotec, CDP Venture Capital and Angelini Ventures launch translational partnership 'Extend' with leading Italian academic Institutions
EQS-News: MorphoSys Presents Preliminary Results from Phase 1/2 Study of Tulmimetostat (CPI-0209) Supporting Its Potential Application in a Broad Array of Advanced Tumors
EQS-News: GSK, MorphoSys’ Licensing Partner, Provides Update on ContRAst Phase III Program for Otilimab in Moderate to Severe Rheumatoid Arthritis
EQS-News: Drägerwerk AG & Co. KGaA: Dräger expects faster sales recognition in the fourth quarter of 2022
EQS-News: Evotec enters partnership with Hannover Medical School to create molecular patient database in autoimmune diseases
Dexcom, Adam Schefter Announce Dexcom U, the First NIL Program for College Athletes With Diabetes
DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the launch of Dexcom U, the first-ever NIL (name, image
EQS-News: MorphoSys Reports Preliminary Q3 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary Q3 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
AEVIS VICTORIA SA – AEVS.SW – Repayment of the CHF 145 million bond issued on 17 October 2016
EQS-Adhoc: STRATEC REPORTS PRELIMINARY FIGURES FOR FIRST NINE MONTHS OF 2022 AND ADJUSTS SALES GUIDANCE
EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft: Changes on the Board of Management
EQS-News: Evotec launches PanOmics data analysis platform PanHunter at Bio-IT World
CORRECTING and REPLACING Humana Announces Major Expansion of Florida Dental Network, Benefits
First bullet point under More Help for Floridians Eligible for Both Medicare and Medicaid section of release dated October 17, 2022, should read: Healthy Options Allowance provides eligible members
EQS-News: Evotec and TIAP expand LAB150 BRIDGE partnership to include Amgen
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures for Q3 2022: net sales and earnings significantly below prior-year level despite continued high order backlog – annual targets no longer achievable
EQS-News: Biotest AG: Biotest AG opens 14th plasma collection centre in the Czech Republic
Waters Automates Solid Phase Extraction of Biological, Food and Environmental Samples with Andrew+ Pipetting Robot
Waters Corporation (NYSE:WAT) today introduced Extraction+ Connected Device, a new software-controlled product for the Waters™ Andrew+™ Pipetting Robot that automates the preparation of biological
Humana Foundation Invests $13 Million in Health Equity Innovation and Creating Healthy Emotional Connections for Vulnerable Populations
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) for the past 40 years, today announced the first grants reflecting its elevated focus on advancing health equity and improving
Waters Marks 25 Years in Ireland with €6 Million Clinical Diagnostics R&D Center Expansion in Wexford
Waters Corporation (NYSE: WAT) today announced a combined investment of up to €6 million with support from IDA Ireland to expand its operations in Drinagh, Wexford to fund research and development
Markteinführung des Dexcom G7 in Großbritannien, Irland, Deutschland, Österreich und Hongkong – Start des globalen Rollouts des weltweit leistungsstärksten Systems zur kontinuierlichen Blutzuckerüberwachung
DexCom, Inc. (Nasdaq: DXCM), der weltweit führende Anbieter von Systemen zur kontinuierlichen Blutzuckermessung in Echtzeit für Menschen mit Diabetes, gab heute die Einführung des Dexcom G7 Systems
Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World’s Most Powerful Continuous Glucose Monitoring System
DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System is now
ADDING MULTIMEDIA Humana significantly expands Medicare Advantage health plan offerings in 2023 with focus on greater value for members
Humana Inc. (NYSE: HUM) today released details of its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2023 – with a clear focus on benefits and support based on what its
Waters Extends Capabilities of Flagship TA Instruments Rheometer for Efficient and Repeatable Powder Analysis
Waters Corporation (NYSE:WAT) today introduced new, innovative powder rheology tooling and software for its TA Instruments™ HR Rheometers allowing scientists to make preciseii, repeatable powder
EQS-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission